In line with this evidence, KDM1A inhibitor, HCI-2509, triggered apoptosis in Ewing sarcoma cell lines, endometrial carcinoma, and AML cells as a single agent, as well as in combination with anticancer drugs [61,62,63]. The gene discussed is KDM1A; the disease is acute myeloid leukemia.